Today marks the first day of vaccinations for Phase I, Part II clinical testing of Sabin's human hookworm vaccine in Brazil.

This month, the Sabin Vaccine Institute will begin a Phase-1 clinical trial in Washington, DC to further investigate the Na-GST-1 human hookworm vaccine candidate.

 

Introduction

Hookworm is an intestinal parasite most commonly found in tropical and subtropical climates worldwide, particularly in Africa, South East Asia, the Western Pacific, Latin America and the Mediterranean. Hookworm is one of three members of a family o

Pages